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Mass spectrometry has frequently been employed in the analysis of biologically relevant
molecules; however, mass spectrometry alone may not always be sufficient for the
differentiation and characterization of isomeric and isobaric ions. In this work, infrared multiple
photon dissociation (IRMPD) spectroscopy and ion mobility spectrometry (IMS) were evaluated
as complementary techniques for the characterization and separation of isomeric and isobaric
ions of biological relevance.
In the first project, analysis of experimental IRMPD spectroscopy data shows that this
technique is useful in the differentiation of hydroxyproline isomers. Absorption bands allow for
the differentiation of three isomeric species: 1640 cm-1 (trans-4-hydroxyproline), 1718 cm-1 (cis4-hydroxyproline), and 1734 cm-1 (cis-3-hydroxyproline). In the second project, theoretical CCS
and IR spectroscopy predictions of isobaric modified amino acids and isomeric drugs have been
carried out as predictions of IMS and IRMPD spectroscopy suitability. Preliminary IMS
measurements suggest that the CCS predictions are at least qualitatively useful.
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CHAPTER I
INTRODUCTION AND REVIEW OF THE LITERATURE
1.1

Chemical Diversity of Biomolecules
Biomolecules encompass a huge variety of molecules—ranging from small molecules to

large, elaborate biopolymers. A single human cell contains a collection of different small
molecules (having molecular weight between 50-1000 Da)1 which are often involved in
metabolism either as substrate, intermediate, or product. These biological small molecules are
called metabolites if they are intermediates or end products of metabolism. Metabolites have
varied chemical structures, including amino acids, fatty acids, saccharides, nucleotides and so
on.2 Some metabolites are also the building blocks for biological polymers, for instance, amino
acids polymerize to form proteins, monosaccharides polymerize to form polysaccharides, and
nucleotides polymerize to form nucleic acids, including deoxyribose nucleic acids and ribose
nucleic acids. The following sections discuss various endogenous and exogenous molecules that
may be found and/or useful in the human body, and which are relevant to the study presented
herein.
1.1.1

Amino Acids
Amino acids are both metabolites and the building blocks of proteins. Chemically, amino

acids contain a central alpha carbon atom (Cα) that is attached to a basic amine (-NH2), a
carboxylic acid (-COOH), a hydrogen atom, and a variable side chain, or “R-group”. The amino
group in each amino acid is a primary amine, with the exception of proline which contains a
1

secondary amine. The 𝛼-carbon atom is a chiral center, except for glycine (where R = H). Hence,
the amino acids can either have L- or D-configuration. Virtually, all the amino acid residues in
proteins found in biological systems have L-configuration.1 D-amino acids are found in some
peptides for instance peptide antibiotics.3 The structures, names, and abbreviations of the amino
acids that form proteins are given in Figure 1.1.

2

Figure 1.1

Structures, names, three letter abbreviations and one letter abbreviations of the
twenty proteinogenic amino acids. The amino acids are categorized based on the
chemical classification of their respective R-groups.

R-group diversity lends functional diversity to amino acids and hence proteins in
biological systems. For instance, the non-polar aliphatic groups, specifically alanine, leucine,
valine, isoleucine and methionine, cluster together within proteins, stabilizing protein structures
3

by hydrophobic interactions.1, 4 Glycine, although a non-polar amino acid, does not play much of
a role in hydrophobic interactions because of its small side chain. Similarly, amino acids with
aromatic side chain (phenylalanine, tyrosine, and tryptophan) also participate in hydrophobic
interactions.4 The amino acids with polar uncharged R-groups (serine, threonine, cysteine,
asparagine, and glutamine) stabilize proteins by participating in hydrogen bonds. Furthermore,
cysteine is capable of forming covalent disulfide (S-S) bonds with other cysteine side chains
which plays an important role in stabilizing the secondary structure of proteins.1, 4 Some amino
acids can be positively or negatively charged at physiological pH (near 7) depending on the
polarity of the R groups. The amino acids with positively charged R-groups at physiological pH
(lysine, arginine and histidine) are typically found near the surface of proteins.4 Amino acids
with negatively charged R-groups (at physiological pH) include aspartic acids and glutamic
acids, which can form salt bridges with nearby positively charged R-groups.1, 4
1.1.2

Non-Proteinogenic Amino Acids
So far, we have discussed proteinogenic amino acids and their roles. However, there are

other amino acids which are not building blocks of protein (hence non-proteinogenic amino
acids) have various roles on the living system such as intermediates in metabolism,
antimetabolite, precursor for different natural products and so on.5 Among the nonproteinogenic amino acids are the modified amino acids.
The chemical diversities of modified amino acid residues are vast, with several having
been reported including phosphorylation,6-8 sulfation,9-12 methylation,13 nitrosylation,14-16
hydroxylation,13 acetylation,13 glycosylation13 and ubiquitylation.13 They are associated with
various roles in the biological system. Tyrosine phosphorylation plays role in cellular
proliferation and differentiation.17 Cell-cycle progression and cellular growth control are often
4

regulated by phosphorylated serine and threonine.18 Ubiquitination has been shown in DNA
damage repair as well as in signaling.19 Tyrosine sulfation has been shown to be involved in
leukocyte adhesion, hemostasis and chemokine signaling.9 Given the diversity of the roles of the
modified amino acids in the biological system, it is imperative that proper analytical technique
for their characterization be developed to fully map their contributions to the active structures of
peptides and correlate those structures with biological function.
Among these various modified amino acids, hydroxylation (hydroxyproline),
phosphorylation (serine and tyrosine) and sulfation (serine and tyrosine) are investigated in this
work. The post-translational modification can result in formation of isomers (for instance, 3hydroxyproline and 4-hydroxyproline) or isobars (for instance sulfoserine and phosphoserine).
Isobars are the species having different atomic elements but same mass number.
The hydroxylation of proline can result in the formation of any one of various isomers of
hydroxyproline, with some shown in Figure 1.2. Hydroxylation of proline has been shown to
impart various biological roles to the isomers. For instance, trans-4-hydroxyproline has been
shown to play an important role in stabilizing the structure of collagen.20-21 On the other hand,
trans-3-hydroxyproline is mostly found in type IV collagen.20-21 Hydroxyproline has been used
as diagnostic marker22-23 as well as in treatment of various diseases24-25 which will be further
discussed in Chapter 2. With these various roles in biological systems, it is useful to develop
proper analytical techniques for separation and differentiation of hydroxyproline isomers.

5

Figure 1.2

Structures of modified proline: cis-3-hydroxyproline (left), cis-4-hydroxyproline
(middle) and trans-4-hydroxyproline (right)

Phosphorylation typically occurs on tyrosine, serine, or threonine,6, 8 though
phosphorylation of lysine, arginine, and histidine residues have also been reported (and their role
has recently been shown to be more widespread than previously believed).26-30 Sulfation is a
well-known modification to tyrosine residues,31 but sulfation of serine and threonine has also
been reported.32 While mass spectrometry-based protein analysis is now widespread,33-34
sulfation and phosphorylation present unique challenges, due to the fact that each result in a
nominal mass shift of 80 amu (e.g., the modifications are “isobaric”). The structure of the
modified amino acids (serine and tyrosine) are shown in Figure 1.3. Hence, an allied technique,
as proposed herein, might be useful for differentiation.

Figure 1.3

Structure of modified serine and tyrosine
6

1.1.3

Biologically Relevant Exogenous Molecules
Thus far, we have discussed endogenous (i.e., naturally occurring) small molecules. In

addition, there are exogenous molecules (for instance, drugs) that are introduced into the body
instead of being produced within. Many of the “exogenous molecules” have isomers that often
have similar or different effects on the human body. For instance, theophylline is a
bronchodilator, while its isomer theobromine is a vasodilator.35 For instance, quinocide, isomer
of antimalarial drug primaquine, is toxic to human health.36 It is therefore essential that the
isomers are differentiated particularly in the cases where one of the isomer are toxic.
In this work, three pairs of isomeric drugs will be used as model systems to represent
these types of isomeric drug molecules. Their structures are shown in Figure 1.4. It is proposed
that an allied technique could be useful for the differentiation of those isomeric drugs on a mass
spectrometry platform.

7

Figure 1.4

1.2
1.2.1

Structure of isomeric drugs used in theoretical studies

Overview of Experimental Approaches
Mass Spectrometry Overview
Mass spectrometry can be used in analysis of analytes, elemental as well as (to some

extent) structural analysis of an analyte and isotopic ratio determination of atoms in an analyte.3738

The basic components of a mass spectrometer (Figure 1.5) are (1) an ionization source, (2) a

mass analyzer, and (3) a detector.37-38 Ions are generated by the ionization source and introduced
to the mass spectrometer. The mass analyzer separates the ions based on their mass-to-charge
ratio (m/z) which are then detected by detectors. Usually, mass analyzer and detector are held at
vacuum while the inclusion of ion source in the vacuum depends on the nature of ionization
source used. To guide and store the ions during the experiment in a mass spectrometer some
additional components (such as ion funnels, ion optics, ion traps, etc.) are required.
8

Figure 1.5

1.1.1.1

Box-diagram of essential component of any mass spectrometer

Electrospray Ionization
Electrospray Ionization (ESI) is a soft ionization technique that can transfer an intact non-

volatile molecule from solution-phase to gas-phase.39-40 In ESI, a dilute solution of analyte is
passed through a needle tip capillary at a very slow flow rate (0.1-10 µL/min). A high voltage (25 kV) is applied to the capillary with a nearby counter electrode. The applied voltage creates a
sufficient electric field to cause charge separation within the liquid which will eventually result
in protrusion of the liquid known as “Taylor cone”.41 Once the Taylor cone reaches Rayleigh
limit (when Coulombic repulsion of the surface charge is equal to the surface tension of the
solution), the droplet detaches itself from the tip and moves toward the counter electrode. The
ejected droplets following desolvation and charge-induced disintegration of droplets will lead to
small highly charged droplets which is then capable of producing gas phase ions. The
desolvation process of ions can be enhanced through instrument modifications, including
(sometimes heated) nebulization gases, heated inlets, etc.42
There are two main models that explain the formation of ions from the ESI droplets.41
These are the ion evaporation model (IEM),43 and the charge residue model (CRM).44 In the
IEM, ions are formed via their evaporation from the droplet surface that contains numerous
analyte ions. In the CRM, a large droplet containing many charged analytes undergo solvent
9

evaporation followed by series of Coulombic fission which will ultimately contain a single ion.
The formation of ions of small analytes is best explained by IEM whereas the formation of large
analyte molecules (e.g., proteins and viruses) ions are better suited by CRM.45
1.2.1.1

Mass Analyzers
There are many possible mass analyzers, including time-of-flight, linear quadrupole, and

ion traps. In this work, the type of mass analyzer used is the quadrupole ion trap (QIT), also
known as “Paul Trap”, so named because it was invented by Wolfgang Paul.46 The QIT
functions as an ion storage device, in which gaseous ions can be confined for certain period of
time, and as a mass spectrometer, where ions can be mass-selectively ejected toward a detector.46
The trapping of ions in an ion trap is possible due to the pseudopotential well created by the
application of suitable radiofrequency potential, along with the presence of an inert background
gas allowing for collisional cooling of the ions toward the center of this pseudopotential well.46
The two subcategories of QITs specifically used in this work are the three-dimensional
ion trap (3D QIT) and linear ion trap (LIT). Results presented in Chapter 2 rely on a 3D QIT.
This device is composed of a central “ring” electrode and two endcap electrodes, which have
holes for ion transmission through the trap. The shape and design of these traps are well-known
and are shown in mass spectrometry textbooks, for instance.47 The 3D QIT uses a threedimensional quadrupole electric field to create stable trajectories for ions of certain m/z or a
range of m/z whereas ions outside that range, with resulting unstable trajectories, are removed by
either colliding them with the walls or ejection through the endcaps.46 Once the ions have been
trapped in the 3D QIT, the AC potential on the ring electrode is ramped, causing the path of ions
to become unstable and to be consecutively ejected in the order of their m/z (lower m/z ejected
first). This ejection mode is referred to as mass-selective instability (ejection) mode. The 3D QIT
10

used to acquire data for Chapter 2 was modified to allow for the passing of infrared photons
through the ion cloud. Such a modification can be achieved by introducing small (e.g., 3 mm)
holes on each side of the ring electrode and integrating IR transparent windows in the vacuum
housing and gold-coated mirrors to direct the laser into the trap and guide it out of the instrument
to measure the pulse energy. The modifications specific to the apparatus used in Chapter 2 have
been previously published in the literature by our collaborators.48
The second type of mass analyzer used for the completion of this work is the other type
of QIT, the LIT.49 The LIT is comprised of an assembly of four parallel rods used for radial
confinement and (some configuration of) endcap electrodes for axial confinement, allowing for
trapping, manipulation and mass-selective ejection of ions with appropriate applied voltages.
Figure 1.649 shows a schematic of a linear quadrupole ion trap, similar to the one used in this
work, equipped with exit slits on each side appropriate for radial ejection. Ions in an LIT are
confined radially (x- and y-directions) by applied RF voltages applied to the rod electrodes
(creating a 2D pseudopotential well) and axially by DC potentials on the endcap electrodes. For
an LIT to operate as an m/z analyzer, a DC voltage is supplied to create the axial trapping field
(z-direction), an RF voltage is supplied to create radial quadrupolar trapping field and
supplemental AC voltage are ramped across the x-rods for ion isolation, activation, and massselective ejection. For radial ejection along x-direction, there are slits in the center segment. Two
detectors are place on either side of the device right beyond the slits which maximizes the
sensitivity.47

11

Figure 1.6

A two-dimensional linear ion trap

Reprinted (adapted) with permission from J. C. Schwartz, M. W. Senko, and J. E. P. Syka. “A
two-dimensional ion trap mass spectrometer”. J. Am. Soc. Mass. Spectrom. 2002, 13, 6, 659669. Copyright (2002) American Society for Mass Spectrometry 2002.

When comparing and contrasting the two types of QITs, the LIT can store a larger
number of ions than 3D QIT, based strictly on the reasonable volume of each device’s
configuration (when an ion cloud of radius of 1.0 mm for QIT and effective cloud length of 30
mm in LIT are compared).49 More specifically, a higher number of ions can be stored before the
negative effects of space charge repulsion (repulsion between particle of same charge in a
confined space), including loss of mass resolution, are observed.50 However, when dealing with
experiments beyond just mass analysis (e.g., introducing lasers), sometimes the 3D QIT is still
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useful, for instance when a compact, space-localized ion cloud is desirable (e.g., for laser/ion
overlap).
1.2.1.2

Ion Detectors
The detectors in both mass spectrometers (used in this thesis) are secondary electron

multipliers (SEM).37-38 An energetic particle impinging on the surface of metal or semiconductor
can result in emission of secondary electrons from the surface. Higher the velocity of the
impinging particles and lower the electronic work function of the surface, higher will be the
number of secondary electrons emitted. An electrode held at higher positive potential, when
placed in opposite location of the emission, results in acceleration of the electrons towards it.
When the electrons hit the surface, each electron will release several more electrons resulting in
avalanche of electrons. Those electrons produced over several stages cause an electric current
which is large enough to be detected by preamplifier.
1.2.1.3

MS Analysis of Isomeric/Isobaric Biomolecules and Inherent Challenges
Therein
Various methods have been employed in differentiation of isomeric/isobaric

biomolecules. Chromatographic techniques have been widely employed to separate isomeric
biomolecules, including prior to mass spectrometric characterization.51-52 Several
chromatographic methods such as gas chromatography (GC), high performance liquid
chromatography (HPLC), supercritical fluid chromatography (SFC), and capillary
electrophoresis (CE) have been employed to separate isomers.53-61 Separation of hydroxyproline
isomers has been achieved using hydrophilic interaction chromatography and reverse phase
liquid chromatography.62-63 Similarly, reverse phase high performance liquid chromatography64
and hydrophilic interaction liquid chromatography65 have been employed to separate isomeric
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phosphopeptides. The use of chromatographic methods in the pharmaceutical,66 toxicological,6768

and metabolic analysis fields69 is also widespread. However, chromatographic approaches

have some general disadvantages. In general, these include high solvent waste streams which
presents both environmental and economic concerns. In most of the cases, the chromatographic
techniques are time consuming (from minutes to hours). Another disadvantage associated with
the chromatographic separation is the solvent compatibility with the mass spectrometer. For
instance, SFC uses high proportion of CO2 can decompress through the transfer line between the
SFC and MS leading to precipitation of analyte and poor repeatability.
Another common approach to structural analysis, and thus differentiation of isomers on
mass spectrometry platforms is tandem or multistage mass spectrometry, with collision induced
dissociation (CID), as the most common reaction.70-71 In CID, ions are accelerated in a collision
cell (or an ion trap) which contains background gas (e.g. He).72 The collision(s) between the ions
and background gas molecules results in transfer of some (or most) of the ions’ kinetic energy
into internal energy. The fragmentation of ions occurs if the internal energy overcomes the ions’
dissociation threshold. Isomeric species from CID can be differentiated if the precursor ions of
the isomer dissociate into different fragment ions or with different characteristic relative
intensities. For instance, differentiation of peptides containing hydroxyproline isomers by
tandem mass spectrometry has been reported where wn-ions (defined as ions resulting from loss
of side chain of C-terminal amino acid) of 3-hydroxyproline isomer is 16 amu heavier than that
of 4-hydroxyproline.73 CID-MS analysis has been successful in differentiation of miglitol (drug
used to treat diabetes) boronate ester isomers.74 However, while CID-MS has been shown to be
useful in differentiation of some isomers, there are many cases where the (protonated) isomers
dissociate via the same fragmentation pathways. For example, isomers of protonated
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hydroxyproline and leucine, upon CID, fragment via the same pathway.75-76 Similarly,
methylenedianiline isomers gave rise to similar dissociation pattern making it difficult for
unambiguous distinction between the isomer pair.77
In the case of isobar differentiation, ultrahigh resolution mass spectrometers for instance
Fourier Transform ion cyclotron resonance mass spectrometers (FTICR)78 or Orbitrap79 mass
spectrometers can be useful. However, these instruments tend to have large footprints (require a
dedicated room as opposed to benchtop instruments), and are quite expensive, relative to more
common, lower-resolution instruments.
1.2.2

Complementary Gas-Phase Approaches: Structural Probing of the Precursor
Given the challenges of many of the approaches to isomer and isobar characterization

presented in the preceding section, it is attractive to think about additional approaches where the
structure of the precursor ion of interest is directly probed in the gas phase. Infrared multiphoton
dissociation (IRMPD) spectroscopy and ion mobility spectrometry (IMS) have both been used in
such structural characterization of gas-phase ions. The structural differences between the
isomers/isobars translates to differences in the vibrational modes (for IRMPD) and collision
cross section (for IMS) which can be useful in differentiating and/or characterization the isomers
and isobars. The following section describe each in detail.
1.2.2.1

Infrared Multiple Photon Dissociation Spectroscopy

1.2.2.1.1

Fundamentals

Infrared multiple photon dissociation (IRMPD), like CID, is a method for achieving gasphase dissociation by way of raising the internal energy of the target ions. As in traditional
infrared spectroscopy, absorption of a resonant infrared photon promotes the ion from the ground
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vibrational state (v=0) to first vibrational state (v=1). In IRMPD, this excitation is followed
rapidly by redistribution of the energy localized to a specific vibrational mode to other
vibrational modes via a process called intramolecular vibrational relaxation (IVR), allowing for
the same transition to be excited again. This process is repeated until the overall internal energy
of the ion exceeds the dissociation threshold after which fragmentation may occur.80-81 The
IRMPD process is depicted in Figures 1.7 and 1.8. Unlike CID, which generally activates ions
regardless of structure, resonant IRMPD can be used to more selectively activate precursor ions,
based on the functional groups that are present.

Figure 1.7

Depiction of IRMPD process.

Dissociation of ion occurs after absorption of multiple photons followed by IVR. The blue circle
represents an ion’s internal energy increasing upon each photon absorption, until it overcomes
the threshold for dissociation (represented here as a fully shaded circle).
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Although the absorption of photons results in increased internal energy of the ions, there
are other competing processes that may lead to the loss of internal energy. Energy loss could be
due to collisional cooling (with the background gas), radiative emission, and/or stimulated
emission. It should be noted that although both CID and IRMPD produce fragment ions via the
lowest-energy fragmentation pathways, the presence of background gas severely limits the
IRMPD efficiency unlike in CID where background gas is a requirement.80-81 This makes the
high vacuum environment of the FTICR an appropriate fit for measurement of the IRMPD
process and thus, such an approach was historically common.81-84 However, coupling IRMPD to
QITs is quite attractive due to the many advantages of QITs. One approach to overcome the
challenge of the different pressure regimes ideal for trapping ions in QITs versus performing
IRMPD in QITs is the implementation of pulsed trapping gas.48, 85 The ions that enter the trap at
higher pressure are trapped and cooled to the center followed by closing the gas valve and
pumping away the gas to allow for maintenance of lower pressure for irradiation and
fragmentation. Another way to achieve sufficient IRMPD in a QIT is the use of laser sources
with high instantaneous power and a tight laser focus, essentially overcoming competitive
collisional cooling by way of brute force.86
By recording IRMPD-MS dissociation yield as a function of irradiation photon
wavelength, an “action” infrared spectrum of mass-selected gas-phase ions can be recorded.
Basically, the mass-selected ions stored in an ion trap are irradiated with IR photons of a
specific, known wavelength (produced from a tunable infrared laser source) as shown in Figure
1.8. The IRMPD mass spectrum is obtained and the IRMPD yield at that wavelength is then
calculated using Equation 1.1. The tunable laser can then be adjusted to produce photons of a
slightly different wavenumber and the experiment can be repeated. By stepping through the
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entire wavelength range of interest and plotting the resulting IRMPD yields as a function of
wavenumber, one can obtain an IRMPD spectrum analogous to an infrared absorption spectrum.
This process is depicted in Figure 1.9.

𝑌𝑖𝑒𝑙𝑑 = −𝑙𝑛

Figure 1.8

𝐼𝑝𝑟𝑒𝑐𝑢𝑟𝑠𝑜𝑟
Σ𝐼𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡𝑠 + 𝐼𝑝𝑟𝑒𝑐𝑢𝑟𝑠𝑜𝑟

(1.1)

Depiction of IRMPD-MS process: selection of precursor ion, IR irradiation, and
fragmentation to produce a fragment ion and a neutral loss molecule
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Figure 1.9

1.2.2.1.2

The IRMPD spectroscopy process: Mass-selected ions are irradiated with IR
photons of varying wavenumbers, the yield for each fragment ions are calculated
by the given equation and plotted as a function of wavenumber

Free Electron Laser

Various types of lasers such as optical parameter oscillator (OPO)87 free electron lasers
(FELs),88 and CO289 lasers have been used to generate IRMPD spectra. The spectral ranges
covered by FELs and OPO are 500-2000 cm-1 and 2500-4000 cm-1 while CO2 lasers have limited
tunability (925-1080 cm-1).80 FELs generally have higher power and wider tunability than the
other commonly used lasers but they require a dedicated facility and are much more expensive.88,
90

Thus, FEL IRMPD spectroscopy is typically performed in one of the few user facilities

worldwide. The data presented in Chapter 2 was recorded at the Free Electron Laser for Infrared
eXperiments (FELIX)91 facility housed at Radboud University in the Netherlands. Since only
FEL data is presented in this thesis, this laser’s basic principles are described herein.
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FELs are tunable laser sources capable of emitting light of large range of wavelengths.
To produce photons, an accelerated electron beam is passed through a magnetic undulator, a
periodic magnetic field, as shown in Figure 1.10. The periodic magnetic field causes the
longitudinally travelling electrons (at relativistic speeds) to oscillate in the transverse direction
which results in release of photons. The wavelength can be tuned by changing the electron beam
velocity or the spacing of the magnets in the undulator.

Figure 1.10

1.2.2.1.3

Schematic representation of components of free electron laser (FEL)

Examples of Application to Isomeric/Isobaric Biomolecules

IRMPD as a dissociation technique and as a method for recording gas-phase IR action
spectra has been used for the characterization of various isomeric/isobaric biomolecular systems.
IRMPD-MS with a CO2 laser has been shown to be useful for characterization of
phosphopeptides83 and saccharides isomers.92-93 Using an OPO, resonant IRPMPD-MS has been
demonstrated for differentiating sulfated versus phosphorylated peptides94 and carbohydrates.95
IRMPD spectra of additional PTMs have also been measured and evaluated for analytical
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characterization methods. PTMs such as oxidation, nitrosylation and nitration have been
studied.96-99 Outside of PTMs, the characterization of carbohydrates has also been a prime target
for IMRPD spectroscopy.100 It has been used in differentiation of several other isomers such as
chondroitin sulfate dissacharides,100 N-acetyl-D-Hexosamine,101 glucosamine,102
glycosaminoglycans.103 Similarly, IRMPD (along with density functional theory) has been
employed in structural elucidation of ion derived from testosterone.104 Quite recently, exciting
advances in the analytical use of IRMPD spectroscopy for the characterization of drugs and
metabolites (including distinguishing between isomeric candidates) has been made. IRMPD has
been successful in differentiating the enantiomers of N-acetylhexosamine (an erroneous
metabolite) in body fluid.105 Similarly, IRMPD has been proved to be a valuable tool for
identification of positional isomers of fluoroamphetamines.106
1.2.2.2

Ion Mobility Spectrometry
There are several types of ion mobility spectrometry,107 but herein we only consider drift-

tube ion mobility spectrometry (DTIMS) as shown in Figure 1.11. Ion mobility spectrometry
(IMS) is a technique in which gas-phase ions are separated based on their mobility as they travel
through a drift cell, with an appropriate background gas, under the influence of an electric
field.107-111
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Figure 1.11

Schematic representation of drift tube ion mobility spectrometry

Ions, under the influence of an electric field, accelerate with a constant drift velocity (𝑣d,
cm s-1) which is given by the equation 1.2:
𝑣𝑑 = 𝐾 ∗ 𝐸

(1.2)

where K is ion’s mobility constant (cm2 V-1 s-1) and E is electric field strength (V cm-1). Unlike
mass spectrometers, ion mobility spectrometers are operated at relatively higher pressure, the
ions experience collision with the background gas which affects ions’ velocity in the drift tube.
Smaller ions experience fewer collisions resulting in higher velocity and shorter drift time,
compared to that of larger ions. The drift time (td) taken by an ion to traverse length (L) of the
drift cell can be used to calculate the velocity of ion, as follows in equation 1.3:
𝑣𝑑 =

𝐿
𝑡𝑑

The ion mobility constant (K) can then be calculated as follows, equation 1.4:
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(1.3)

𝐾=

𝐿2
𝑡𝑑 𝐸

(1.4)

An ion’s mobility is often defined by reduced mobility constant (K0) to normalize the
constant to standard conditions so that measurements between the laboratories can be compared,
using the Equation 1.5:

𝐾0 = 𝐾

273.15 𝑃
𝑇
760

(1.5)

Apart from mobility constant, collision cross section (CCS, Ω) is also a characteristic
value of an ion. The CCS value (measured in Å2) can be calculated using Mason-Schamp
equation,108-109 as follow in Equation 1.6:

(18π)1/2
𝑧𝑒
1
1 1/2 𝑡𝑑 𝐸 760 𝑇 1
𝛺=
[ +
]
16 (𝑘𝐵 𝑇)1/2 𝑚𝑖 𝑚𝑏
𝐿 𝑃 273.15 𝑁

(1.6)

where ze is the charge on the ion, kB is the Boltzmann constant, mi is the mass of the
analyte ion, mb is the mass of the buffer gas, td is the drift time, E is the electric field strength, L
is the length of the drift tube, P is the drift tube pressure, T is the temperature of the drift tube,
and N is the gas number density. The drift time of an ion should be reproducible under a given
set of experimental conditions and can thus be used in compound identification.
There are several advantages of ion mobility spectrometry107, 112 such as speed, easy
coupling with chromatographic techniques and mass spectrometry, and improved selectivity.
IMS data are typically acquired within 100 ms time scale, which makes it easier to be coupled
after the pre-separation techniques such as GC or LC because the separation time for
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chromatographic methods are usually several minutes and the peaks are several seconds wide.
Co-eluted compounds can be separated which can further improve selectivity. Coupling ion
mobility to mass spectrometry offers an advantage of isomer separation that would be nearly
impossible using mass spectrometry alone.113-115 Additionally, IMS can be used as a stand-alone
technique without coupling to mass spectrometer.116
Unfortunately, IMS is not devoid of limitations. Most of the commercially available
instruments operate at reduced pressure and hence have low resolving power. IMS, when used
as a stand-alone technique, lacks specificity when a mixture of compounds with similar mobility
are analyzed.
The ion mobility used in this work operates at atmospheric pressure. Separation by IMS
is dependent on ion/neutral gas interactions that scale with pressure and hence this approach is
referred to by its developers as “high performance ion mobility spectrometry” HPIMS,
analogous to HPLC, because of the relatively high resolution achieved using a relatively short
drift tube path length.117
Theoretical CCS values can be calculated by several methods such as projection
approximation (PA),118-119 exact hard sphere scattering (EHSS),119-120 and the trajectory method
(TM).119, 121 The theoretical results obtained with TM method has been demonstrated to be most
accurate among the three methods.119-121 This is because the TM includes the effect of short
range and long range interactions as well as the thermal velocity distribution while the other two
methods fail to do so. The prediction of CCS value with the abovementioned methods has been
achieved by the use of MOBCAL software program.118-121 Initially, the CCS value prediction by
MOBCAL software used helium as the buffer gas. However, recently MOBCAL software
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program has been modified to calculate the CCS122-123 in N2 buffer gas (instead of helium) since
it has been increasingly used as buffer gas due to availability and lower cost.
1.2.2.2.1

Examples of Application to Isomeric/Isobaric Biomolecules

IMS has emerged as a powerful alternative technique for isomeric separation and its use
in separation of isomers of small molecules has been increasing. It has been used in
differentiation of various isomeric molecules of glycans and glycopeptides.115, 124-130 For
instance, travelling-wave ion mobility spectrometry (TWIMS) has been employed in separation
of high-mannose-N-glycans.124 Differentiation of disaccharide isomers has been achieved
utilizing high-field asymmetric waveform ion mobility spectrometry (FAIMS).125 Similarly, IMS
has been useful in differentiation of isomeric lipids.131-134 In addition to glycans and lipids,
isomeric amino acids,135-136 steroids,137-141 and peptides142-145 have been differentiated using IMS.
For instance, IMS has been successful in separation of enantiomeric D and L amino acids135 and
diastereomeric hydroxyproline isomers.146
1.3

Perspective Overview
The purpose of this thesis work was to elaborate the application of mass spectrometry

along with the allied techniques in differentiation of isomeric/isobaric molecules that are
biologically relevant. The goal of Chapter 1 was to provide appropriate context for the work
presented in this thesis. In Chapter 2, IRMPD spectroscopy is used as an allied technique for
differentiation of hydroxyproline isomers. In Chapter 3, theoretical CCS prediction and
theoretical IR spectroscopy have been employed to determine the suitability of the two
techniques. Some preliminary experiments have also been carried to determine whether CCS
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predictions could be useful or not. Finally, Chapter 4 concludes the work presented in this thesis
and provides future works that could be continued.
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CHAPTER II
ANALYSIS OF INFRARED ION SPECTROSCOPY DATA FROM HYDROXYPROLINE
ISOMERS
2.1

Introduction
The nature and location of post-translational modifications (PTMs) of protein plays

important role in regulation of protein function.12-13, 147 Several PTMs such as phosphorylation,
sulfation, hydroxylation, nitrosylation, and methylation are covalently modified. Relevant to the
aims of this chapter, the presence of several isomeric forms of hydroxyproline (trans-4-, cis-4-,
trans-3-, and cis-3-hydroxyproline) can arise from hydroxylation by various biological and
fungal enzyme.21, 148-151 The isomers have different biological roles. For example, trans-4hydroxyproline, found extensively in collagen, plays an important role in stabilizing the triple
helical structure of the collagen; whereas, trans-3-hydroxyproline is found mostly in type IV
collagen.20-21, 152 Cis-hydroxyproline, on the other hand, has been shown to have inhibitory effect
on collagen synthesis in bovine retinal pigment epithelial cells.22, 153
Hydroxyproline quantitation in urine and serum have been used in diagnosis of several
diseases.22-24 For example, determining the level of hydroxyproline in urine and serum can be
useful in diagnosis of thyroid disease and Marfan’s syndrome (genetic disorder that affects the
connective tissues in the body), evaluation of pathological changes in diseases affecting the
bones as well as evaluation of therapy used for treatment of thyroid diseases.22 Additionally,
increased level of urinary hydroxyproline is believed to be a potential early marker of kidney
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injury especially fibrosis.24 Other than diagnostic marker, hydroxyproline has shown promising
results in treatment of diseases as well.25, 154-157 Given the importance of hydroxyproline in living
being as well as its potential for diagnosis and treatment of disease, additional methods for
characterization and differentiation of its isomers would be useful. Additionally, fundamental
studies in understanding the conformational differences between the biologically relevant
isomers are of interest.
IMS (here, travelling wave ion mobility spectrometry was used) along with density
functional theory study of metal ion cationized hydroxyproline have shown that the lithiated
trans-4-hydroxyproline exists in the salt-bridge conformation while lithiated cis-4hydroxyproline exists in the charge-solvated conformation.146 The study of gas phase amino
acid-metal complex conformation is a well-established subfield within the gas-phase ion
community.158-164 It is well known that amino acids complexed with metal cations can exist in
either charge-solvated (CS) form or salt-bridge (SB) form. In the CS form, the metal ion is
chelated with electron rich site(s) whereas in SB form the metal ion interacts with the
carboxylate ions of the amino acid. The structures of conformers are shown in Figure 2.1. The
mid-IR region, which covers C=O stretching modes, is often useful in determining the presence
of either SB or CS conformer. Various IRMPD spectroscopy studies have been reported on the
SB or CS conformation of amino acids adducted with various metal cations.158-161
Here, three isomers of hydroxyproline (cis-3-hydroxyproline, cis-4-hydroxyproline and
trans-4-hydroxyproline) to represent both positional isomers (cis-3- and cis-4-hydroxyproline)
and stereoisomer (cis-4-hydroxyproline and trans-4-hydroxyproline) are chosen for analysis. The
structures are shown in Figure 1.2. The main goal of this IRMPD spectroscopy study is to
differentiate stereoisomers and positional isomers. It is also shown that lithiated hydroxyproline
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isomers are differentiated better than protonated hydroxyproline isomers. A secondary goal is to
predict the conformation of the isomers based on IRMPD spectra and previously reported
literature. The results discussed herein comprise part of a recently published article from our
group.165
2.2

Methods
IRMPD spectroscopy was carried out by Dr. Patrick and our collaborators (Drs. Giel

Berden and Jonathan Martens) at the FELIX facility at Radboud University in Nijmegen, the
Netherlands. The full experimental details are provided in a co-authored manuscript, along with
complementary computational results carried out by a group mate.165 Herein, the experimental
methods are briefly described, followed by a detailed description of data processing and analysis
performed by the author (BA).
2.2.1

Experimental Method
The hydroxyproline isomers (cis-3-, cis-4-, and trans-4-hydroxyproline) were purchased

from Santa Cruz Biotechnology (Heidelberg, Germany). Spray solutions were made to ~10 -100
µM in 50/50 water/methanol. To aid in protonation, ~0.5% acetic acid was added. For lithiation
studies, spray solution containing ~ 1:1 hydroxyproline:lithium chloride were evaluated and
lithium chloride concentration was tuned to obtain ideal signal of lithiated precursor ion. The
IRMPD spectra, obtained in the region of 500-1900 cm-1, were acquired using a tunable infrared
laser source, the Free Electron Laser for Infrared eXperiments (FELIX), coupled to a modified
quadrupole ion trap mass spectrometer (Bruker, AmaZon Speed ETD).48
The gas-phase lithiated precursor ions were mass trapped and isolated in a quadrupole ion
trap. The trapped mass-selected ions were irradiated with the IR photons. If the photons at
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certain wavelength is on-resonance then the precursor ions will absorb the photons. The
wavelength are increased step-wise from 500 cm-1 to 1900 cm-1. When the internal energy of
ions surpasses the dissociation threshold, fragmentation occurs.
2.2.2

Data Processing and Analysis
From IRMPD-MS data, neutral losses were assigned by finding the difference (∆m/z)

between the precursor ion and the fragments. The losses were assigned based on the structure of
precursor ion structure, previously reported (known) losses, and chemical intuition. For instance,
the difference of 18 amu was attributed to loss of water. The mass difference of 46 amu can be
attributed to loss of H2O and CO, or H2CO2. Loss of CO2 results in mass difference of 44 amu
whereas loss of CO2 and H2O corresponds to difference of 62 amu.
The IRMPD yield of the IRMPD spectroscopy experiment was calculated using Equation
2.1. Equation 2.1 has the advantage that the intensities can be readily corrected for changes in IR
pulse energy and irradiation time. The yield was linearly corrected for variation in laser power at
each wavelength. The power-corrected IRMPD yield as a function of wavenumber was plotted to
obtain the IRMPD spectra.
Yield = −𝑙𝑛

2.3
2.3.1

𝐼𝑝𝑟𝑒𝑐𝑢𝑟𝑠𝑜𝑟
∑𝐼𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡(𝑠) + 𝐼𝑝𝑟𝑒𝑐𝑢𝑟𝑠𝑜𝑟

(2.1)

Results and Discussions
IRMPD-MS and IRMPD Spectroscopy of Protonated Positional Isomers
The IRMPD-MS of the protonated isomers of hydroxyproline are shown in Figure 2.1.

Both protonated isomers (cis-3-hydroxyproline and cis-4-hydroxyproline) dissociate to produce
the same fragment ions by losing water and carbon monoxide. This is in agreement with the
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previously reported literature where CID-MS of hydroxyproline isomers gave rise to the same
fragment ion via the loss of H2O and CO.75 Hence, the differentiation by CID-MS is not possible
here. On the other hand, IRMPD might be a useful approach in such a differentiation, as has
previously been exhibited for differentiation of isomers.105-106

Figure 2.1

IRMPD-MS spectra of protonated cis-3-hydroxyproline (left) and cis-4hydroxyproline (right). Both isomers give rise to same fragment ions (loss of H2O
+ CO).

Reprinted (adapted) with permission from B. Acharya, W. K. D. N. Kaushalya, J. Martens, G.
Berden, J. Oomens, and A. L. Patrick. “A Combined Infrared Ion Spectroscopy and
Computational Chemistry Study of Hydroxyproline Isomers”. J. Am. Soc. Mass. Spectrom.
2020, 31, 6, 1205-1211. Copyright (2020) American Chemical Society.
The IRMPD spectra of protonated positional isomers (cis-3-hydroxyproline and cis-4hydroxyproline) are shown in Figure 2.2. Figure 2.2 A and B show spectra of cis-3hydroxyproline and cis-4-hydroxyproline, respectively. While a unique absorption band to any of
the isomers cannot be seen, qualitative differences are observed. As shown in Figure 2-2, at
around ~1214 cm-1 there is a dip in the yield for cis-3-hydroxyproline whereas a peak in
dissociation yield can be seen for cis-4-hydroxyproline (blue guide line in Figure 2.2). Similarly,
at ~1271 cm-1, a peak is observed in the yield for cis-3-hydroxyproline whereas cis-4hydroxyproline exhibits a trough in the yield (orange guide line in Figure 2.2). Additionally,
there are other minor differences in the IRMPD spectra of the two isomers. The absorption band
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in cis-3-hydroxyproline at ~1780 cm-1 red shifts to ~1770 cm-1 in the spectrum of cis-4hydroxyproline. The differences seen in those isomers can allow for fingerprinting of the
isomers, but more distinctive differentiation may be desirable. The absorption band at ~1770 cm1

is well-established as the C=O stretch.75, 158, 160-162 Hence, the bands seen in this study can be

assigned to the C=O stretch.

Figure 2.2

IRMPD spectra protonated positional isomer: A) cis-3-hydroxyproline B) cis-4hydroxyproline. The guide lines show the specific difference between the two
spectra.

Reprinted (adapted) with permission from B. Acharya, W. K. D. N. Kaushalya, J. Martens, G.
Berden, J. Oomens, and A. L. Patrick. “A Combined Infrared Ion Spectroscopy and
Computational Chemistry Study of Hydroxyproline Isomers”. J. Am. Soc. Mass. Spectrom.
2020, 31, 6, 1205-1211. Copyright (2020) American Chemical Society.
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2.3.2

IRMPD-MS and IRMPD Spectroscopy of Lithiated Hydroxyproline Isomers
The IRMPD-MS of lithiated hydroxyproline isomers are shown in Figure 2.3. The

lithiated hydroxyproline isomers also give rise to some common peaks upon laser induced
dissociation (though with some differences). The common dissociation pathways seen in all three
isomers are combined loss of carbon dioxide and water. With the IR photons at on-resonance
wavelength (where the isomer absorbs the IR photons) and a relatively high power, extensive
dissociation can be seen, while when the laser power is attenuated there is less extensive
dissociation. When the IR photons are tuned to an off-resonance wavelength (where the isomers
do not absorb at all), no dissociation is seen. The lithiated positional isomers of hydroxyproline
show some differences in the fragmentation pathway. Lithiathed cis-4-hydroxyproline loses H2O
and CO which is absent in the IRMPD-MS of the lithiated cis-3-hydroxyproline. Based on
previous IMS study, it is hypothesized that IRMPD spectroscopy will be able to give more
distinct differences and provide conformational insights. The fundamental driving force for the
differences in IRMPD-MS pathways is a topic of ongoing research in our laboratory.
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Figure 2.3

IRMPD-MS of lithiated cis-3-hydroxyproline (top panel), cis-4-hydroxyproline
(middle panel) and trans-4-hydroxyproline (bottom panel). The left column
(“Laser ON, High Power”) shows dissociation when high laser power is used at
on-resonance wavenumber, the middle column (“Laser ON, Low Power”) shows
less extensive dissociation when low laser power is used at on-resonance
wavenumber and the third column (“Laser OFF”) shows no dissociation when
laser is used at off-resonance wavenumber

Reprinted (adapted) with permission from B. Acharya, W. K. D. N. Kaushalya, J. Martens, G.
Berden, J. Oomens, and A. L. Patrick. “A Combined Infrared Ion Spectroscopy and
Computational Chemistry Study of Hydroxyproline Isomers”. J. Am. Soc. Mass. Spectrom.
2020, 31, 6, 1205-1211. Copyright (2020) American Chemical Society.

The IRMPD spectra of lithiated positional isomers are shown in Figure 2.4. An
absorption band at ~1718 cm-1 and ~1734 cm-1 can be seen for cis-4-hydroxyproline (middle
panel) and cis-3-hydroxyproline (top panel) which corresponds to a difference of ~16 cm-1
between the positional isomers. The difference between the absorption band at this region is
shown by solid line Figure 2-5. The difference, although minor, is greater than seen for the
protonated positional isomers. Lithiated cis-3-hydroxyproline shows a peak at ~1163 cm-1 while
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it is seen around ~1174 cm-1 in lithiated cis-4-hydroxyproline. In addition to above-mentioned
differences between the lithiated positional isomers, a unique absorption at 1093 cm-1 for cis-3hydroxyproline is seen which is absent from cis-4-hydroxyproline.
Compared to the positional isomers, the differences between the spectra of lithiated cis-4hydroxyproline (Figure 2.4, middle panel) and trans-4-hydroxyproline (Figure 2.4, bottom panel)
is even more distinct. Trans-4-hydroxyproline shows an absorption band at ~1640 cm-1 while cis4-hydroxyproline shows the absorption band at ~1718 cm-1. The difference of ~78 cm-1 is greater
than previously reported for protonated species (difference of ~20 cm-1).75 Additionally, an
absorption band unique to cis-4-hydroxyproline is seen at ~1168 cm-1 which is absent from the
spectra of the trans-4-hydroxyproline. Similarly, trans-4-hydroxyproline has a peak at ~1546 cm1

whereas cis-4-hydroxyproline lacks a peak at this position. There are some other minor

differences seen in the absorption of the two isomers. Absorptions band seen at 1173 cm-1, 1267
cm-1 and 1433 cm-1 in cis-4-hydroxyproline are observed around 1201 cm-1, 1281 cm-1, 1416 cm1

in tran-4-hydroxyproline.
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Figure 2.4

IRMPD spectra of lithiated isomers of hydroxyproline A) cis-3-hydroxyproline B)
cis-4-hydroxyproline and C) trans-4-hydroxyproline. The distinct IR features in the
spectra are shown by the dashed line. The solid line represent the carbonyl stretch
region with difference between peak labeled (∆) at the top of the figure

Reprinted (adapted) with permission from B. Acharya, W. K. D. N. Kaushalya, J. Martens, G.
Berden, J. Oomens, and A. L. Patrick. “A Combined Infrared Ion Spectroscopy and
Computational Chemistry Study of Hydroxyproline Isomers”. J. Am. Soc. Mass. Spectrom.
2020, 31, 6, 1205-1211. Copyright (2020) American Chemical Society.
Given the differences in the spectra of all the three isomers, it can be concluded that
lithiation helps in unambiguous differentiation of the three isomers at 1093 cm-1, 1640 cm-1, and
1734 cm-1 (wavenumbers unique to cis-3-hydroxyproline, trans-4-hydroxyproline and cis-4hydroxyproline respectively).
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2.3.3

Salt Bridge vs Charge Solvated Structure of Stereoisomers
The absorption bands corresponding to charge solvated and salt bridge conformations of

amino acids adducted with metal cations in the gas phase have been established in the literature
and are summarized in Table 2.1. The presence of absorption band between the region of 1650
cm-1 to 1700 cm-1 is indicative of SB conformer whereas between the region of 1700 cm-1 to
1800 cm-1 is indicative of CS conformer.158-164 An absorption band at around 1450 cm-1 which
corresponds to NH3+ bending may be seen for SB conformer.159, 161
Table 2.1

Absorption frequencies and predicted conformation of metal ion cationized amino
acids

Absorption Frequencies
1650-1700 cm-1
1450 cm-1
1700-1800 cm-1

Assigned Conformation
SB
SB
CS

References
158-164
159, 161
158-164

Based on the previous literature reports, it can be concluded that lithiated cis-3hydroxyproline and cis-4-hydroxyproline adopt the CS conformation, given that they exhibit
absorption at 1734 cm-1 and 1718 cm-1, respectively.
Absorption in the region 1566 cm-1 to 1670 cm-1 is indicative of SB structure. It can thus
be concluded that the absorption band at 1640 cm-1 seen for lithiated trans-4-hydroxyproline is
the asymmetric carboxylate stretch, indicative of a SB structure. In the literature, the IRMPD
spectra of potassiated proline (a SB conformer) has a shoulder to the blue side of the absorption
band which has been attributed to the contribution from minor fraction of the CS conformer.158
Likewise, the shoulder to the blue side seen in the IRMPD spectrum (Figure 2.3, bottom panel)
of lithiated trans-4-hydroxyproline may indicate the presence of minor population of the CS
conformer.
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2.4

Summary
IRMPD spectroscopy and IRMPD-MS has been employed for differentiation of

stereoisomers and positional isomers of hydroxyproline. While the protonated positional isomers
had minor differences in their IRMPD spectra, lithiated isomers showed larger differences in
their IRMPD spectra. Among the lithiated isomers, distinct differences in the IRMPD spectra
were seen among the stereoisomers. On the other hand, when comparing the IRMPD-MS
spectrum, differences between positional isomers are seen. The presence of loss of water and
carbon monoxide in lithiated cis-4-hydroxyproline, while absent in lithiated cis-3hydroxyproline, can be the distinguishing peaks to different the positional isomers. Based on the
previous IRMPD and IMS study, it is inferred that the lithiated cis-3-hydroxyproline and
lithiated cis-4-hydroxyproline adopts a charge solvated structure whereas lithaited trans-4hydroxyproline adopts a salt bridge structure. The assignment of salt bridge or charge solvated
structure was based on the absorption band seen in the IRMPD spectra. The salt-bridge structure
has carbonyl stretch region at around 1600 cm-1 whereas charge solvated structure has around
1700 -1800 cm-1. These results imply that infrared ion spectroscopy can be use in differentiation
of closely related isomers for modified amino acids
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CHAPTER III
ANALYSIS OF BIOLOGICALLY RELEVANT ISOMERIC/ISOBARIC MOLECULES:
PREDICTION OF SEPARATION BY ION MOBILITY SPECTROMETRY AND
DIFFERENTIATION BY INFRARED ION SPECTROSCOPY
3.1

Introduction
Isomeric/isobaric small molecules are widely prevalent in living systems and in

pharmaceuticals, often with distinctly different roles. For instance, the isobaric PTMs
(phosphorylation and sulfation) have various roles in biological systems.166-168 Phosphorylation
plays key roles in cellular proliferation and differentiation,17 cell-cycle progression, and cellular
growth control.18 Whereas sulfation is known to play a key part in leukocyte adhesion,
hemostasis and chemokine signaling.9 Exogenous molecules, including those arising from
nutrition, pharmaceuticals, and toxicity, may exist in isomeric/isobaric forms, with different
functions in living system. The positional isomers primaquine and quinocide have different
effects on the living system. Primaquine is an antimalarial drug while its positional isomer is a
toxic contaminant.36 Another isomer pair included in this study, theophylline and theobromine,
also have different pharmacological effect on human beings. Theophylline is a bronchodilator
(widens bronchi) whereas theobromine is a vasodilator (widens the blood vessels), diuretic
(increased urine production), and heart stimulator.35 Isoquinoline derivatives have diverse roles
in the living systems such as anesthetics, antihypertensive, and vasodilators.169 The derivatives of
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quinoline, however have different effects than those of isoquinoline derivatives. The various
effects include antimalarial, anticancer, antiviral, antibacterial, and antiprotozoal.170
Chromatographic techniques are used for the separation of isomeric/isobaric species.54,
60, 171-172

However, chromatographic techniques often requires longer time to separate the

isomers. Tandem mass spectrometry is incapable of differentiation of closely related isomeric
species specially if they dissociate via the same fragmentation pathways. For instance, the
isomers of protonated hydroxyproline isomers dissociate via the same pathway.75 The modified
amino acids used in this project also undergo loss of the sulfate/phosphate group (as shown in the
section below) which makes it difficult for their differentiation. Therefore, it is worth exploring
alternative approaches to separation and characterization of such species. Here, two approaches,
IMS and IRMPD spectroscopy, are evaluated (primarily through theoretical modeling) for
separation and characterization, respectively, of five sets of isobaric and/or isomeric molecules.
It is important to note that the theoretical CCS calculations are carried out in N2 gas at
low pressure while the IMS experiment in this work is carried out in air as drift gas and at
atmospheric pressure. Since the CCS value is dependent on gas as well as pressure of the
instrument, exact CCS value may not be predicted. However, the theoretical prediction should be
somewhat similar to the experimental values (for instance, the prediction of drift time trends
from CCS values should explain the drift time obtained from experimental results).
Infrared spectra can be predicted by finding the potential energy minimum for given
molecule with respect to the coordinates of all atoms in the molecule is necessary using density
functional theory (DFT). Here, functionals such as B3LYP and M06-2X with different basis sets
have been employed to predict the potential energy minima and ultimately the IR frequencies.
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This chapter presents the results of the theoretical predictions of CCS and IR spectra of
four sets of isobaric and isomeric species, along with some preliminary experimental
measurements.
3.2
3.2.1

Methods
Computational Method
For each studied molecule, many conformers (about 60-100) were sampled for the

(de)protonated species, using using Gabedit software.173 The isomeric/isobaric molecule
conformations then were optimized using density functional theory at M06-2X/6-311+G(d,p)
level of theory using Gaussian 09 program.174 The level of theory was chosen because it has been
shown to reproduce the experimental IRMPD spectra of sulfoserine.175 The theoretical
frequencies were then scaled by a factor of 0.940.175 Avogadro software was used for
visualization of the structures.176 The lowest energy conformers were then submitted to gasphase collision cross section calculation using the trajectory method (TM) in the MOBCAL
software.122-123 In the CCS calculations N2 was used as drift gas.
3.2.2

Experimental Method
Modified amino acids (sulfoserine, phosphoserine, sulfotyrosine and phosphotyrosine)

were purchased from Bachem Americas Inc (Torrance, CA). The stock solution was prepared in
50/50 HPLC grade methanol/water. The spray solution was then diluted with HPLC grade
methanol to the final concentration of 10 ppm. Phosphotyrosine did not dissolve completely in
1:1 water: methanol solvent. The stock solution was centrifuged, and the supernatant solution
was taken and diluted. The IMS analysis was carried out on a Thermo Scientific LTQ XL linear
ion trap mass spectrometer (San Jose, CA) to which an add-on drift tube ion mobility
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spectrometer source (Excellims Corp., Acton, MA) was combined. This IMS instrument used is
an atmospheric drift tube ion mobility spectrometer in which the drift region is ~10 cm long. The
ESI source voltage was held at -2039 V. The drift tube temperature and voltage were 180.0 °C
and drift tube voltage of 10000V. The buffer gas (air) flow was 1.5 L/min.
Since various modes of operation has been employed in IMS, they will be briefly
discussed here. In Faraday mode operation, IMS is used as stand-alone device. Among the two
gates, the first gate pulses the ions into the drift tube while second gate is always open. Faraday
mode allows the measurement of drift time. In open mode both gates are opened, and the ions
pass through the drift tube to the MS unrestricted. Drift time cannot be calculated when operated
in this mode. Ions formed can be determined from the mass spectra obtained. Another mode of
operation, gated mode, allows the passage of ions of selected mobilities via the drift tube to the
mass spectrometer. Operation in gated mode requires selective accumulation of ions based on
their mobility before MS analysis. This mode is particularly useful to improve the selectivity,
remove interfering molecules and isolate conformation states. This mode helps identify the ions
present at the selected drift time.
3.3
3.3.1
3.3.1.1

Results and Discussion
Modified Amino Acids
Theoretical Results
The lowest energy conformers found for modified amino acids (deprotonated) are shown

in Figure 3.1. There are two possible deprotonation sites of the modified amino acids, the
carboxylic acid and the sulfo-/phospho- group. The energetically favorable deprotonation site of
the sulfated amino acids has been shown to be the sulfate group instead of the carboxyl group.175
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Similarly, the favored deprotonation site for phosphorylated amino acids is the phosphate
group.177 Thus, conformers with these deprotonation sites were considered.
The predicted CCS of the isobars at low pressure with N2 as drift gas are presented in
Table 3.1. The CCS value of phosphoserine is higher than that of sulfoserine predicting the
shorter drift time of sulfoserine. Similarly, between sulfotyrosine and phosphotyrosine,
sulfotyrosine has a shorter drift time. The fragment ions (deprotonated) seen from sulfoserine
and phosphoserine (Figure 3.1) at m/z 97, assigned as deprotonated sulfuric and phosphoric acid
were also subjected to CCS calculation to MOBCAL software after the energy optimization
process. The theoretical prediction showed that HSO4- had smaller CCS value (shown in Table
3.1), and hence a shorter predicted drift time, as compared to H2PO4-. In each case, the
phosphorylated systems are shown to have longer predicted drift times than the sulfated systems.

Figure 3.1

Lowest energy conformers of deprotonated amino acids and their deprotonated
fragments
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Table 3.1

Predicted CCS of modified deprotonated amino acids (and their fragment ions)
Predicted Collision Cross Section (Å2)

Molecules
Sulfoserine

135.12

Phosphoserine

146.39

Sulfotyrosine

181.58

Phosphotyrosine

188.44

Sulfuric acid

117.90

Phosphoric acid

128.04

3.3.1.2

Preliminary IMS Study of Modified Serine
The ion mobility-mass spectrometry data were collected separately for sulfoserine and

phosphoserine. The sulfoserine and phosphoserine solutions produced peaks centered at 6.8501
and 6.9601 ms respectively as shown in Figure 3.2. However, in Faraday mode it is not clear
what ions are contributing to this signal. Thus, to get a better understanding of the ions
contributing to this signal, the IMS was operated in gated mode. For the preliminary analysis of
the gated mode, the drift time was selected from 6.5 – 7.5 ms. The IMS-gated MS scan of the
sulfoserine and phosphoserine solutions can be seen in Figures 3.2 and 3.3. The mass spectra of
both species show peaks m/z at 97 and 80. This indicates that the signal contributing to the drift
time are deprotonated fragments of the modified amino acids. The deprotonated fragments were
then subjected to CCS calculations. As predicted by theoretical CCS calculation, deprotonated
sulfuric acid has shorter drift time as compared to the deprotonated phosphoric acid.
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Figure 3.2

Overlay of drift time (ms) spectra of deprotonated sulfoserine (red) and
phosphoserine (black)

Figure 3.3

Mass spectra of sulfoserine when IMS was gated from 6.5 – 7.5 ms
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Figure 3.4

Mass spectra of phosphoserine when IMS was gated from 6.5 – 7.5 ms

The mass spectra obtained from open mode of operation for sulfoserine can be seen in
Figure 3.5. The full scan mass spectrum in open mode produces peaks assigned to deprotonated
([M-H]-) sulfoserine at m/z 184, deprotonated sulfuric acid (HSO4-) at m/z 97, and SO3- at m/z 80.
Similarly, Figure 3.6 shows the mass spectra of phosphoserine obtained from open mode of
operation. The full scan shows ions at m/z 184, 97 and 80 for deprotonated phosphoserine,
deprotonated phosphoric acid (H2PO4-) and HPO3- respectively.
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Figure 3.5

Full scan mass spectra of sulfoserine when IMS is operated in open mode

Figure 3.6

Full scan mass spectra of phosphoserine when IMS is operated in open mode
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The CID-MS of sulfoserine (normalized collision energy 15) and phosphoserine
(normalized collision energy 12) are shown in Figures 3.7 and 3.8 respectively. Both sulfoserine
and phosphoserine produce fragment ion at m/z 97 which can be identified as HSO4- and H2PO4respectively. This indicates that CID-MS is incapable of separation of sulfoserine and
phosphoserine.

Figure 3.7

CID-MS of deprotonated sulfoserine (m/z 184, normalized collision energy 15)
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Figure 3.8

3.3.1.3

CID MS of phosphoserine (m/z 184, normalized collision energy: 12)

Preliminary IMS Study of Modified Tyrosine
The overlay of drift time spectra of sulfotyrosine and phosphotyrosine is shown in Figure

3.9. The drift time for sulfotyrosine and phosphotyrosine are 9.0001 and 9.0201 ms respectively.
The separation of modified tyrosine is not achieved in deprotonated mode.
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Figure 3.9

Overlay drift time spectra of sulfotyrosine and phosphotyrosine

To determine the ions contributing to drift time signals, the IMS was operated in gated
mode. The mass spectra of sulfotyrosine and phosphotyrosine from gated mode operation are
shown in Figures 3.10 and 3.11, respectively. Interestingly, the mass spectra shows numerous
neutral losses for modified tyrosine which are absent from mass spectra of modified serine.
However, deprotonated tyrosine (seen at m/z 180) in both sulfo- and phospho-tyrosine are
probably responsible for the similar drift time. In addition to tyrosine ion with m/z 118 seems to
be involved in contribution to the drift time signal. For sulfotyrosine this fragment arises due to
loss of deprotonated sulfuric acid and carbon dioxide whereas for phosphotyrosine the fragment
arises due to loss of deprotonated phosphoric acid and carbon dioxide, both giving rise to
essentially similar fragment ions.
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Figure 3.10

Mass spectra of sulfotyrosine when IMS is operated in gated mode from 8-5 -9.5
ms. The neutral losses associated with the labeled peaks are shown in Table 3.2.
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Figure 3.11

Mass spectra of phosphotyrosine when IMS is operated in gated mode from 8.5 –
9.5 ms. The labeled peaks are assigned in Table 3.2.

Table 3.2

Peak assignment for Figures 3.10 and 3.11
Peaks
A
B
C
D
E
F
G
H

m/z
260
215
198
180
163
135
119
79

Peak Assignment
Sulfotryosine
Phosphotyrosine
[M-H]
[M-H][M-H-COOH][M-H-COOH][M-H-H2O-CO2][M-H-H2O-CO2][M-H-SO3][M-H-PO3H][M-H-HSO4][M-H-H2PO4][M-H-HSO4-CO][M-H-H2PO4-CO][M-H -HSO4-CO2][M-H -H2PO4-CO2][M-H-Tyr][M-H-Tyr]-
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This warranted a full scan mass spectra of modified tyrosines to see whether the modified
tyrosine would give similar neutral losses as that of gated mode. The full scan mass spectra of
modified amino acids when IMS is operated in open mode are shown in Figures 3.12 and 3.13.
For both species, the mass spectra showed high amount of neutral losses giving peaks at same
m/z similar to that in gated mode. For instance, loss of COOH, and H2O and CO2 are seen in both
species that give rise to m/z 215 and 198.

Figure 3.12

Full scan mass spectra of sulfotyrosine when IMS is operated in open mode. The
labeled peaks are assigned in Table 3.3
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Figure 3.13

Full scan mass spectra of phosphotyrosine when IMS is operated in open mode.
The labeled peaks are assigned in Table 3.3

Table 3.3

Peak assignments for Figures 3.12 and 3.13
Peaks
A
B
C
D
E
F
G
H
I

m/z
282
260
215
198
180
163
135
119
79

Peak Assignment
Sulfotryosine
Phosphotyrosine
[M-H+H2O]
[M-H+H2O][M-H][M-H][M-H-COOH][M-H-COOH][M-H -H2O-CO2][M-H-H2O-CO2][M-H-SO3][M-H-PO3H][M-H-HSO4][M-H-H2PO4][M-H-HSO4-CO][M-H-H2PO4-CO][M-H-HSO4-CO2][M-H -H2PO4-CO2][M-H-Tyr][M-H -Tyr]-
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The CID MS of both sulfo- and phospho-tyrosine are shown in Figure 3.14 and 3.15.
Comparison of these two spectra shows fragment ions at same m/z values making it difficult to
separate by CID MS. Both modified acids give tyrosine as fragment ion (due to loss of sulfate
from sulfotyrosine and phosphate from phosphotyrosine). Some additional neutral losses (that
are common to both) are H2O, HCOOH, H2O and CO2. The amount of neutral losses in modified
tyrosines are too low as compared to the modified serine. The neutral losses from CID are
labeled above the peaks.

Figure 3.14

CID MS of sulfotyrosine (m/z 260, normalized collision energy: 18)

55

Figure 3.15

3.3.2

CID MS of phosphotyrosine (m/z 260, normalized collision energy: 20)

Isomeric Drug Molecules
After modified amino acids, isomeric drugs were evaluated. The lowest energy

conformers of the isomeric drugs (protonated) are shown in Figure 3.16. Quinoline and
isoquinoline (Figure 1.4) have only one protonation site and cannot form deprotonated ions. The
CCS value (Table 3.4) of quinoline is smaller than isoquinoline and hence quinoline should have
shorter drift time than isoquinoline. The structure of theophylline and theobromine are shown in
Figure 1.4 while the lowest energy conformers of the isomer pair are shown in Figure 3.16. The
protonated isomers were analyzed since no deprotonation sites are available. Theobromine has
smaller cross section and hence should have smaller drift time as compared to theophylline.
Primaquine and quinocide (Figure 1.4) have three possible protonation sites with no
deprotonation site. The lowest energy conformer of primaquine and quinocide are shown in
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Figure 3.16. The theoretical CCS of primaquine is larger as compared to that of quinocide. It can
be inferred, from the CCS value, that quinocide will arrive at the detector faster than primaquine.

Figure 3.16

Lowest energy conformer of protonated isomeric drug isomers

Table 3.4

Predicted CCS value of the protonated isomeric drug molecules

Molecules

Predicted Collision Cross Section (Å2)

Quinoline

139.17

Isoquinoline

152.50

Primaquine

163.92

Quinocide

163.11

Theophylline

141.49

Theobromine

141.18
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The theoretical IR spectra (in the FEL and OPO region) of protonated quinoline and
isoquinoline drugs are shown in Figure 3.17 and 3.18. While the IR spectra of the isomer pair in
the FEL region are similar (Figure 3.17), the IR spectra in the OPO region shows some
differences (Figure 3.18). Specifically, quinoline exhibits an absorption band around 3336 cm-1
whereas isoquinoline shows a peak around 3358 cm-1. Similarly, quinoline an absorption peak is
seen around 3028 and 3065 cm-1 in quinoline whereas isoquinoline shows around 3065 cm-1. The
vibrational modes in the OPO region are listed in Table 3.5.

Figure 3.17

The theoretical IR spectra of protonated isoquinoline (red trace) and quinoline
(black trace) at M06-2X/6-311+C(d,p) level of theory. The scaling factor was
0.940.
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Figure 3.18

The theoretical IR spectra of protonated isoquinoline (red trace) and quinoline
(black trace) in the OPO region at M06-2X/6-311+G(d,p) level of theory. The
scaling factor was 0.940.

Table 3.5

Unique IR peaks (cm-1) of quinoline and isoquinoline along with the vibrational
mode
Wavenumber (cm-1)
Quinoline
3028, 3065
3336

Isoquinoline
3033
3358

Vibrational Modes
CH stretch
NH stretch

The predicted IR spectra of the isomer pair theobromine and theophylline in the FEL and
OPO region are shown in Figure 3.19 and 3.20. The most distinct differences between the two IR
spectra of the isomer pair can be seen in the NH and C=O stretch regions. Absorption peaks seen
at 1772 and 1817 cm-1 in theophylline shift to 1793 and 1843 cm-1 (Figure 3.21). However, more
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marked differences can be observed in the NH stretch region where the absorption band at 3325
cm-1 seen in theobromine shifts to 3385 cm-1 in theophylline. The vibrational modes for the
abovementioned wavenumbers are included in Table 3.6.

Figure 3.19

The theoretical IR spectra of protonated theophylline (red) and theobromine
(black) in the FEL region at M06-2X/6-311+G(d,p) level of theory. The scaling
factor was 0.940.
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Figure 1.12

The theoretical IR spectra of protonated theophylline (red) and theobromine
(black) zoomed in to 1600-2000 cm-1 at M06-2X/6-311+G(d,p)

Table 3.6

Unique IR peaks (cm-1) of theophylline and theobromine along with the vibrational
mode
Wavenumber (cm-1)
Theophylline
Theobromine
1772
1793
1817
1843
3184
3200
3385
3325

Vibrational Mode
C=O stretch
NH stretch

The predicted IR spectra (Figures 3.22 and 3.23) of protonated primaquine and quinocide
show remarkable differences which can be useful in differentiation of the isomers. An absorption
peak observed at 2132 cm-1 for primaquine shifts to 2227 cm-1 in quinocide. Similarly, a peak
seen around 3143 cm-1 for primaquine is seen 3177 cm-1 for quinocide (Figure 3.23). The
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absorption band at 3365 cm-1 is present in primaquine while is absent in the spectrum of
quinocide. While differentiation (and characterization) of protonated quinoline and isoquinoline
may not achieved by IRMPD of the protonated species alone, the differentiation of other two sets
of protonated isomer pairs seems to be possible based on the predicted IR spectra. The
vibrational modes of abovementioned wavenumbers are summarized in Table 3.7.

Figure 3.20

The theoretical IR spectra of protonated primaquine (red) and quinocide (black) in
the 500-2500 cm-1 region at M06-2X/6-311+G(d,p) level of theory. The scaling
factor was 0.940.
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Figure 3.21

The theoretical IR spectra of protonated primaquine (red) and quinocide (black) in
the OPO region at M06-2X/6-311+G(d,p). The scaling factor was 0.940.

Table 3.7

Unique IR peaks (cm-1) of primaquine and quinocide along with the vibrational
mode
Wavenumbers (cm-1)
Primaquine
2132
3143
3296
3365

Quinocide
2227
3177
3319
--
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Vibrational Modes
NH stretch
NH stretch
NH2 stretch
NH2 stretch

3.4

Discussion of Future Directions and Approaches to Troubleshooting
In the literature in cases where sufficient separation has not been achieved, various

approaches have been employed in improving the separation of isomer separation by IMS such
as different charge carrier,129, 146, 178 use of different drift gases,114 and use of gas modifiers.179
Different charge carriers have been used in order to increase the differences in drift time
of isomeric analytes to achieve sufficient separation. For instance, baseline resolution of
hydroxyproline stereoisomers in travelling wave ion mobility spectrometry was achieved by
metal ion cationization while the drift time of protonated species was perfectly overlaid.146
Similarly, use of sodium as charge carrier has been found to increase the differences in drift time
of prostaglandin isomers as compared to the protonated isomers.114 Similarly, separation of
structural and positional isomers of carbohydrates have been improved by metal ion adducts.180 It
is often seen that metal ion cationization shows an advantage of better separation of isomers than
protonated counterparts.140, 178
Another approach in improving the separation of isomers is the use of different drift
gases. For instance, use of mixture of CO2 and air as drift gas has improved the separation of
corticosterone isomers as compared to 100% air.114 Similarly, S-(+)-butanol as chiral gas
modifier has been able to improve the separation of atenolol enantiomers.179
The separation between isobaric serine and tyrosine as well as isomeric drugs maybe
improved by altering the charge carrier, and/or using different drift gas.
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CHAPTER IV
CONCLUSIONS AND FUTURE DIRECTIONS
4.1

Conclusions
IRMPD spectroscopy and IMS have been explored as alternative approaches in

differentiation and characterization of isomers and isobaric ions. This work has shown that
IRMPD spectroscopy and IRMPD-MS may provide a path towards differentiation of
hydroxyproline isomers. Preliminary theoretical calculations have been done in order to predict
the CCS and IR spectra of several isobars and isomers. IMS has has been employed in an attempt
to differentiate the isobars.
In the first project (Chapter 2), IMRPD-MS spectra and IRMPD spectroscopy spectra
were analyzed for protonated and lithiated stereoisomer and positional isomers of
hydroxyproline. It was shown that lithiation of the isomers induced greater differences in the
IRMPD spectra as compared to protonated isomers. The distinct absorption bands seen for trans4-hydroxyproline, cis-4-hydroxyproline and cis-3-hydroxyproline are at ~1640, 1718 and 1093
cm-1. The lithiated positional isomers showed minor differences in the IRMPD spectra as
compared to the IRMPD spectra of lithiated stereoisomers. On the other hand, upon laser
induced dissociation, lithiated stereoisomers fragmented via similar pathways. Between
positional isomers, unique peaks were seen specifically in cis-4-hydroxyproline. Lithiated cis-4hydroxyproline showed neutral loss of water and carbon monoxide which was not seen in
lithiated cis-3-hydroxyproline.
65

In the second project (Chapter 3), theoretical modeling to predict the utility of IMS and
IRMPD spectroscopy as an alternative structural probing approach for differentiation of isobars
and isomers have been explored. The CID-MS and full scan spectra of modified amino acids had
similar peaks making it difficult to separate the isobars by MS only. Modified serines were better
separated than modified tyrosines. The drift time signal of modified serine was contributed by
the deprotonated acids whereas that for tyrosine was contributed by tyrosine. Predicted IR
spectra of the isomer pairs, specifically theophylline and theobromine and primaquine and
quinocide, show remarkable differences which can be useful in the differentiation of the isomers.
4.2

Future Works
One of the ways to move forward with this project would be the IMS study of modified

amino acids. In the current study, the drift times for modified amino acids are contributed either
by the deprotonated acids or the amino acids itself. Better separation may be achieved if the
deprotonated precursor ion could be formed. To do so, the effect of ESI parameters, drift tube
voltage, and the drift gas flow could be explored to minimize precursor ion dissociation insource. Similarly, exploring different charge carrier, drift gas, and drift gas modifier could be
useful approach to improve the separation among the isobars and isomers. Once the
differentiation has been achieved, post-translationally modified (isobaric) peptides and proteins
can also be explored. Similarly, the drug isomers that are modeled in Chapter 3 can be analyzed
experimentally by IRMPD spectroscopy. This would help in realizing whether the used
functionals and basis set are able to adequately predict the IR spectra or not for the classes of
compounds investigated herein.
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APPENDIX A
COORDINATES OF LOWEST ENERGY CONFORMERS OF BIOLOGICALLY RELEVANT
ISOMERS AND ISOBARS
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A.1

Coordinates of lowest energy conformer of deprotonated phosphoserine (Figure 3.1)
at M06-2X/6-311+G(d,p) level of theory
-1

1

N

-2.439081

1.739133

-0.311680

H

-3.164092
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O
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H
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H
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O
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P
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O
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H
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O
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2.174183

-0.666017
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1.993432

-1.608086

1.263957
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A.2

Coordinates of lowest energy conformer of deprotonated sulfoserine (Figure 3.1) at
M06-2X/6-311+G(d,p) level of theory
-1

1

N

-1.068721

1.336166

1.287767
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A.3

Coordinates of lowest energy conformer of deprotonated phosphoric acid (Figure
3.1) at M06-2X/6-311+G(d,p) level of theory
-1

1

P

0.000014
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O
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O
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A.4

Coordinates of lowest energy conformer of deprotonated sulfuric acid (Figure 3.1)
at M06-2X/6-311+G(d,p) level of theory
-1

1
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O
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O
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O
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H
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-0.000026
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A.5

Coordinates of lowest energy conformer of deprotonated phosphotyrosine (Figure
3.1) at M06-2X/6-311+G(d,p) level of theory
-1

1

N

-3.160686

0.676702

1.403680

H

-2.252102

1.108795
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C

-3.386849
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H
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C
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O
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-0.416493

C
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H
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H
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-1.225895
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-0.529281

H
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-1.862322

-0.536294

C

-0.672923
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-0.752986

H

-1.310667
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-0.941619

C
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-0.681572

-0.284818

H

1.626212

-1.528442

-0.083907

C
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1.700991

-0.512625

H

1.116580

2.692920

-0.505530

C

1.526336

0.613082

-0.270490

O

2.820364

0.895737

-0.057211

P

4.011030

-0.241094

0.366408
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O

-5.606465

0.551093

0.533190

H

-3.144992

0.283938

2.338485

H

-4.965078

1.141251

0.981872

O

5.256829
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0.448715

O
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-1.113937

-1.034579

H

4.610383
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-1.658424

O
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-1.116623
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A.6

Coordinates of lowest energy conformer of deprotonated sulfotyrosine (Figure 3.1)
at M06-2X/6-311+G(d,p) level of theory
-1

1

N

3.015751
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1.512708

C

3.318035

-0.440365
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H
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C

2.711559

0.200193

-0.933008
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H
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C
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H
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C
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H

0.787173
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-0.939796

C

-0.715863

1.775838

-0.408854

H

-1.164226

2.750254

-0.257217

C

-0.996774

-0.614362

-0.581822

H

-1.636116

-1.486464

-0.579290

C

-1.553637

0.657343

-0.380501

O

-2.860936

0.903628

-0.176905

S

-3.949361

-0.357850

0.279676

O

5.511222

0.436358

0.787809
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H

4.835632

0.918999

1.309094

H

2.944944

-0.198940

2.345121

H

2.113354

0.830845

1.396053

O

-3.986932

-1.217105

-0.899141

O

-3.292851

-0.946311

1.441878

O

-5.138316

0.429639

0.535886

91

A.7

Coordinates of lowest energy conformer of protonated quinoline (Figure 3.16) at
M06-2X/6-311+G(d,p) level of theory
1

1

C

1.259590

-1.410787

0.000000

C

2.438615

-0.718886

0.000000

C

2.439305

0.698431

0.000000

C

1.268277

1.414222

0.000000

C

-1.216114

1.408883

0.000000

C

-2.377200

0.703093

0.000000

N

-2.329235

-0.666665

0.000000

C

-1.195436

-1.356834

0.000000

C

0.034823

-0.693995

0.000000

C

0.032628

0.733692

0.000000

H

3.381347

-1.251289

0.000000

H

1.245926

-2.494473

0.000000

H

1.279049

2.497435

0.000000

H

3.387048

1.223635

0.000000

H

-3.362079

1.147399

0.000000

H

-1.251586

2.490887

0.000000

H

-3.207183

-1.176381

0.000000

H

-1.274804

-2.437472

0.000000
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A.8

Coordinates of lowest energy conformer of protonated isoquinoline (Figure 3.16) at
M06-2X/6-311+G(d,p) level of theory
1

1

C

1.259590

-1.410787

0.000000

C

2.438615

-0.718886

0.000000

C

2.439305

0.698431

0.000000

C

1.268277

1.414222

0.000000

C

-1.216114

1.408883

0.000000

C

-2.377200

0.703093

0.000000

N

-2.329235

-0.666665

0.000000

C

-1.195436

-1.356834

0.000000

C

0.034823

-0.693995

0.000000

C

0.032628

0.733692

0.000000

H

3.381347

-1.251289

0.000000

H

1.245926

-2.494473

0.000000

H

1.279049

2.497435

0.000000

H

3.387048

1.223635

0.000000

H

-3.362079

1.147399

0.000000

H

-1.251586

2.490887

0.000000

H

-3.207183

-1.176381

0.000000

H

-1.274804

-2.437472

0.000000
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A.9

Coordinates of lowest energy conformer of protonated primaquine (Figure 3.16) at
M06-2X/6-311+G(d,p) level of theory
1

1

C

-2.812487

0.707973

-0.035766

C

-1.857051

1.689915

0.092602

C

-0.472895

1.354355

0.070199

C

-0.099597

0.055284

-0.076228

N

-0.585501

-2.254577

-0.369316

C

-1.468643

-3.216937

-0.496185

C

-2.866068

-2.991946

-0.482172

C

-3.338676

-1.716157

-0.333642

C

-2.420223

-0.645670

-0.194459

C

-1.050881

-0.990420

-0.218168

N

1.298706

-0.336789

-0.112614

H

0.247558

2.157732

0.176539

O

-2.098060

3.001726

0.245514

H

-3.868643

0.942765

-0.020120

H

-1.080561

-4.222908

-0.617924

H

-4.403720

-1.512536

-0.321697

H

-3.541400

-3.830585

-0.590619

C

-3.453174

3.428566

0.289293

H

-3.963396

3.189914

-0.647700

H

-3.421780

4.505789

0.425562

H

-3.975837

2.965242

1.130345
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C

2.062627

-0.172419

1.182942

H

1.294366

-1.336912

-0.367960

H

1.945222

0.880613

1.456352

C

3.540873

-0.484027

0.940203

C

1.446672

-1.067660

2.246285

H

3.989373

-0.595629

1.930456

C

4.369479

0.551568

0.163561

H

3.625896

-1.470426

0.465633

H

4.182841

1.554035

0.568228

C

4.195192

0.575026

-1.353299

H

5.423595

0.343555

0.361492

N

2.874400

1.121791

-1.739395

H

4.261682

-0.441478

-1.751258

H

1.830919

0.240385

-0.870794

H

2.737465

1.050921

-2.744367

H

1.945672

-0.897890

3.200572

H

1.565391

-2.120828

1.977857

H

0.383221

-0.861288

2.377469

H

2.836151

2.114966

-1.520489

H

5.006346

1.153081

-1.803424
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A.10

Coordinates of lowest energy conformer of protonated quinocide (Figure 3.16) at
M06-2X/6-311+G(d,p) level of theory
1

1

C

-3.121770

0.473089

-0.052790

C

-3.009537

-0.883742

-0.231012

C

-1.728325

-1.499966

-0.213458

C

-0.587840

-0.767245

-0.054797

N

0.483209

1.387109

0.193732

C

0.378769

2.687795

0.364190

C

-0.851863

3.373105

0.434477

C

-2.008286

2.655843

0.298226

C

-1.949654

1.252859

0.113154

C

-0.663407

0.656974

0.089216

N

0.697522

-1.401647

-0.035321

H

-1.694123

-2.579669

-0.315344

O

-4.029702

-1.737728

-0.407379

H

-4.082258

0.970285

-0.037039

H

1.308190

3.244311

0.450360

H

-2.975529

3.145478

0.331315

H

-0.863294

4.444718

0.583653

C

-5.347492

-1.208003

-0.398747

H

-5.567554

-0.738525

0.563909

H

-6.010787

-2.054233

-0.553974

H

-5.478873

-0.483837

-1.207260
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C

1.328523

-1.431462

1.313495

H

0.586635

-2.360494

-0.356873

H

1.207576

-0.440438

1.752197

C

2.809217

-1.799904

1.251883

H

0.789509

-2.143310

1.945793

H

3.105189

-2.083899

2.264361

C

3.763921

-0.688976

0.784882

H

2.947807

-2.699403

0.639152

H

3.486291

0.263316

1.254581

C

3.897990

-0.478450

-0.722734

H

4.768137

-0.924546

1.145421

N

2.599536

0.033247

-1.271276

H

4.064427

-1.443081

-1.211292

C

5.014029

0.490482

-1.080254

H

5.081752

0.647270

-2.159034

H

5.971624

0.095458

-0.740219

H

4.857006

1.457805

-0.595074

H

1.780574

-0.614946

-0.963246

H

2.628903

0.153341

-2.283210

H

2.318906

0.920868

-0.833472
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A.11

Coordinates of lowest energy conformer of protonated theophylline (Figure 3.16) at
M06-2X/6-311+G(d,p) level of theory
1

1

N

0.023357

1.461858

0.244327

C

1.405633

0.769977

0.256993

N

1.445605

-0.563789

0.004879

C

0.335771

-1.462934

-0.110367

C

-0.938070

-0.777020

0.010662

N

-2.213986

-1.264755

-0.014733

C

-3.044908

-0.205342

0.143211

N

-2.383955

0.934628

0.265120

C

-1.101318

0.558980

0.185098

H

-4.119388

-0.305155

0.164866

O

0.484214

-2.633746

-0.282987

C

2.810544

-1.136966

-0.040687

O

2.321764

1.494300

0.459232

C

-0.011605

2.488284

-0.873442

H

3.275827

-1.041332

0.939279

H

3.396594

-0.595628

-0.780635

H

2.714390

-2.182380

-0.316509

H

-0.969046

3.000151

-0.804746

H

0.071308

1.946207

-1.813925

H

0.826925

3.164690

-0.727190

H

-2.474593

-2.237326

-0.129363
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H

-0.003269

1.980871

1.132307
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A.12

Coordinates of lowest energy conformer of protonated theobromine (Figure 3.16) at
M06-2X/6-311+G(d,p) level of theory
1

1

N

1.449260

-0.861040

-0.229410

C

2.027547

0.569161

-0.241208

N

1.134232

1.559100

0.007235

C

-0.293823

1.525238

0.100444

C

-0.787654

0.169917

-0.032493

N

-2.064675

-0.323010

-0.034381

C

-1.950715

-1.659924

-0.198936

N

-0.689064

-2.064420

-0.299485

C

0.002190

-0.929751

-0.199729

H

-2.813070

-2.308864

-0.240577

O

-0.917679

2.527509

0.263062

O

3.190389

0.656523

-0.431004

C

2.079689

-1.640666

0.911240

H

1.698748

-2.657508

0.848608

H

1.767176

-1.165559

1.839674

H

3.158834

-1.597159

0.784426

H

1.541594

2.491810

0.039561

C

-3.299447

0.457098

0.103923

H

-4.137596

-0.235804

0.080768

H

-3.376413

1.164392

-0.719852

H

-3.284469

0.995411

1.049645
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H

1.788533

-1.279824

-1.105878

101

APPENDIX B
MOBCAL INPUT

102

obabel -iout filename.out -osdf -m
sdf2tinkerxyz<filename.sdf
python xyztomfj_mmff_mmffcharge.py filename.out.xyz filename.out.key filename.mfj
gfortran mobcal_MMFF_Exp6_nitrogen.f -o mobcal
mobcal filename.mfj filenameccs.out 1000 0.98 0.81 (for helium as buffer gas)
mobcal filename.mfj filenameccs.out 1000 0.76 0.86 (for nitrogen as buffer gas)
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